Abstract
Background
There is overwhelming evidence for the antidiabetic effect of obesity surgery, but few reports involve objective longitudinal measurements of severity of type-2 diabetes mellitus (T2DM). This study applies a grading scheme and analyses the prognostic impact of routine clinical factors.
Material and Methods
This retrospective study includes 77 obese diabetic patients with a preoperative BMI of 48.9 ± 7.8 kg/m2 who underwent gastric banding (n = 4), Roux-en-Y gastric bypass (n = 57), or sleeve gastrectomy (n = 16) between 2007 and 2013. A 6-point scoring system graded the level of antidiabetic therapy. Downgrading was calculated from the difference between pre- and postoperative grades.
Results
Downgrading reached its maximum at 3 months well before maximal weight loss: one grade in 6 (8 %) patients, two grades in 36 (47 %) patients, and three or more grades in 20 (26 %) patients. Age, gender, and preoperative weight had no impact on downgrading. There were no significant differences between gastric banding (median 1; 0–2), gastric bypass (median 2; 0–5), and sleeve gastrectomy (median 2; 0–4). Preoperative duration of T2DM and its severity grade were independent prognostic factors in multivariate analysis. The rate of patients who could discontinue insulin was more than 80 % when the duration of preexisting T2DM was less than 5 years as compared to 62 % when the duration was more than 5 years.
Conclusion
The severity of T2DM downgrades in most patients within the initial period of postoperative weight loss. Downgrading increases with shorter duration and lower severity grade of pre-existing T2DM.
Similar content being viewed by others
References
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. Discussion 350–2 PMID: 7677463.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5. PMID: 19272486.
Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with BMI <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70. PMID: 22051116.
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ. 2013;347:f5934. PMID: 24149519.
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. PMID: 22449317.
Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. PMID: 18212316.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8. PMID: 21339423.
Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. PMID: 22449319.
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. PMID: 14530719.
Jurowich C, Thalheimer A, Hartmann D, et al. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery—who fails in the early postoperative course? Obes Surg. 2012;22(10):1521–26. PMID: 22588846.
Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50. PMID: 20524158.
Blackstone R, Bunt JC, Cortes MC, et al. Type 2 diabetes after gastric bypass: Remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis. 2012;8(5):548–55. PMID: 22721581.
Rosenstock J, Banarer S, Fonseca VA, et al. The 11-β-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care. 2010;33(7):1516–22. PMID: 20413513.
Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–35. PMID: 19875608.
Rubino F. Is type 2 diabetes an operable intestinal disease? a provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:290–6. PMID: 18227499.
Fischer JE. The implications for the surgical community of bariatric surgery as a “cure” for type 2 diabetes. Am J Surg. 2013;206(1):136–41. PMID: 23790217.
Pinkney JH, Johnson AB, Gale EA. The big fat bariatric bandwagon. Diabetologia. 2010;53(9):1815–22. PMID: 20623218.
Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg. 2006;202(1):70–7. PMID: 16377499.
DeMaria E, Winegar E, Pate V, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg. 2010;252(3):559–67. PMID: 20739857.
World Health Organisation. 2013. Type 2 Diabetes - Definition. [cited 16/10/2013]. Available from: http://www.who.int/diabetes/action_online/basics/en/index1.html.
World Health Organisation 2011, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus- Abbreviated Report of a WHO consultation, [cited 16/10/2013]. Available from: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf
DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53. PMID: 20510288.
Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss. Ann Surg. 2003;237(6):751–8. PMID: 12796570.
Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8. PMID: 22723580.
Shimizu H, Timratana P, Schauer PR, et al. Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI<35 kg/m2. J Obes. 2012; 2012:9 pages. Article ID 147256. PMID: 22720136.
Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: Comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52. PMID: 17940829.
Manger T, Stroh C. Surgery in morbid obesity: Quality assurance- state of the art and prospects. Obes Facts. 2011;4 Suppl 1:29–33. PMID: 22027287.
Gill RS, Sharma AM, Gill SS, et al. The impact of obesity on diabetes mellitus and the role of bariatric surgery. Maturitas. 2011;69(2):137–40. PMID: 21493021.
Schernthaner G, Brix JM, Kopp HP, et al. Cure of type 2 diabetes by metabolic surgery? a critical analysis of the evidence in 2010. Diabetes Care. 2011;34(2):355–60. PMID: 21525482.
Lebovitz HE. Metabolic surgery for type 2 diabetes with BMI <35 kg/m2. An endocrinilogist’s perspective. Obes Surg. 2013;23(6):800–8.
Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8. PMID: 19733515.
Parikh M, Ayoung-Chee P, Romanos E, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg. 2007;205(5):631–5. PMID: 17964437.
Hutter MM, Schirmer BD, Jones DB, et al. First report from the American college of surgeons bariatric surgery center network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–22. PMID: 21865942.
Pories WJ, The IDF. Statement: a big and long-awaited step for our diabetic patients. Obes Surg. 2011;21(10):1487–9. PMID: 21847715.
Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9. PMID: 20303324.
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–29. PMID: 10998650.
Acknowledgments
The authors thank Dr Philip Sedgwick BSc, PhD, FSS, Reader in Medical Statistics and Medical Education, Institute of Medical and Biomedical Education, St. George’s, University of London, for his statistical assistance.
Conflict of Interest Statement
The authors have no conflict of interest to declare.
Statement of Informed Consent
Informed consent was obtained from all individual participants included in the study.
Statement of Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”
For this type of study formal consent is not required.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Runkel, M., Müller, S., Brydniak, R. et al. Downgrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter. OBES SURG 25, 494–499 (2015). https://doi.org/10.1007/s11695-014-1419-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-014-1419-3